4
Changes in Ownership
GENELUX Corp Filed Acc 0001415889-24-030004
VP, Pharmaceutical Development acquired 29,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cappello Joseph VP, Pharmaceutical Development | 2024-12-18 | Grant or award | +29,000 | 43,653 | D | ||
| Derivatives | |||||||
| Cappello Joseph VP, Pharmaceutical Development | 2024-12-18 | Grant or award · Stock Option (right to buy) | +39,000 | 39,000 | D | ||
Loading xslF345X05/form4-12212024_011239.xml…